Olanzapine Market Size

ID: MRFR/Pharma/0247-HCR

130 Pages

Rahul Gotadki

September 2025

Olanzapine Market Research Report, by Application (Schizophrenia, Bipolar disorder, other) by types (ZYPREXA tablets, ZYPREXA ZYDIS and ZYPREXA Intra Muscular), by region (Europe, Americas, Asia Pacific and Middle East & Africa)- Forecast to 2032

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Olanzapine Size

Olanzapine Market Growth Projections and Opportunities

The dynamics of Olanzapine’s market are affected by various factors that control this factor including the dimension in which it is placed. The primary one among them is the prevalence and diagnosis of mental health disorders. For example, as schizophrenia and bipolar disorders increase in number, so does the demand for olanzapine. In addition, prescription behavior by medical professionals has a significant impact on the development of this market. The overall picture is also influenced by doctors’ preferences based on how efficient and tolerable the drug would be. Research and development activities undertaken by pharmaceutical companies have had a major impact on shaping the olanzapine market. Continued improvements in psychiatric studies alongside new forms of treatment can lead to innovation and may eventually influence growth within its sphere. Introduction of novel formulations or combinations may alter prescribing patterns thereby affecting competitive environment within the market. Olanzapine’s market size is shaped greatly by patient demographics and socio-economic factors. This means that those regions suffering high incidences of mental illness or are accessible to healthcare services might require more medications than other parts of the world. Besides, economic factors such as health care spending plus insurance coverage will affect whether patients can access or afford Olanzapine. Olanzapine’s performance in the global economic landscape is highly dependent upon it but not exclusively so; however, since some economies do not grow this way as they decline with time though at different rates depending on what happens worldwide at any given moment like political tensions, natural disasters or even health epidemics such as COVID-19 pandemic which has hampered many countries from attaining their set objectives through implementation measures towards recovery efforts after these kinds of situations occurred. Economic downturns reduce healthcare budgets and increase pricing pressure, potentially impacting profitability for firms involved in manufacturing and distributing olanzapine while growth periods accompanied with higher healthcare spendings can have opposite effect on market expansion. In modern pharmaceutical industry including olanzapine market, technological developments and adoption of digital health solutions are becoming increasingly important. For example, there exist various digital tools for diagnosis, treatment monitoring and patient support that can improve the whole experience of treatment thus affecting market by means of bettering patient adherence and outcomes.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

The global Olanzapine market is projected to grow from 2.65 USD billion in 2024 to 3.58 USD billion by 2035.

Key Market Trends & Highlights

Olanzapine Key Trends and Highlights

The market is expected to experience a compound annual growth rate (CAGR) of 2.77 percent from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 3.58 USD billion, indicating a steady growth trajectory.
In 2024, the market is valued at 2.65 USD billion, reflecting the current demand for Olanzapine.
Growing adoption of Olanzapine due to its efficacy in treating schizophrenia and bipolar disorder is a major market driver.

Market Size & Forecast

2024 Market Size	2.65 (USD Billion)
2035 Market Size	3.58 (USD Billion)
CAGR (2025-2035)	2.77%
Largest Regional Market Share in 2024	latin_america)

Major Players

Dr. Reddy’s Laboratories, Watson Pharmaceuticals, Lilly, Hamson Pharmaceuticals, Sun Pharmaceuticals, Sandoz Pharmaceuticals, Torrent Pharmaceuticals, Jubilant Life Sciences

Market Trends

The global demand for Olanzapine appears to be driven by an increasing prevalence of mental health disorders, alongside a growing recognition of the importance of effective treatment options in psychiatric care.

U.S. National Institute of Mental Health

Olanzapine Market Market Drivers

Market Trends and Projections

The Global Olanzapine Market Industry is projected to experience notable growth over the coming years. With a market value of 2.65 USD Billion in 2024, it is anticipated to reach 3.58 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 2.77% from 2025 to 2035. These figures reflect the increasing demand for olanzapine as a treatment option for various mental health disorders, driven by factors such as rising prevalence rates, advancements in pharmaceutical research, and enhanced mental health services.

Advancements in Pharmaceutical Research

Ongoing advancements in pharmaceutical research are propelling the Global Olanzapine Market Industry forward. Innovations in drug formulation and delivery methods enhance the efficacy and safety profiles of olanzapine, making it a more appealing option for healthcare providers and patients alike. Research into personalized medicine and genetic factors influencing drug response is also gaining traction, potentially leading to more tailored treatment approaches. These developments may foster increased adoption of olanzapine, thereby driving market growth. The market is anticipated to grow at a CAGR of 2.77% from 2025 to 2035, reflecting the positive impact of these advancements on the Global Olanzapine Market Industry.

Rising Prevalence of Mental Health Disorders

The increasing incidence of mental health disorders globally is a primary driver for the Global Olanzapine Market Industry. Conditions such as schizophrenia and bipolar disorder are becoming more prevalent, necessitating effective treatment options. According to estimates, the number of individuals diagnosed with these disorders continues to rise, leading to a growing demand for antipsychotic medications like olanzapine. This trend is expected to contribute significantly to the market, with projections indicating that the market could reach 2.65 USD Billion in 2024. As awareness of mental health issues increases, the Global Olanzapine Market Industry is likely to expand to meet the needs of this growing patient population.

Increased Investment in Mental Health Services

The growing recognition of mental health as a critical component of overall health has led to increased investment in mental health services worldwide. Governments and private organizations are allocating more resources to improve access to mental health care, which includes the provision of medications like olanzapine. This trend is particularly evident in regions where mental health services have historically been underfunded. As these investments continue, the Global Olanzapine Market Industry is likely to benefit from enhanced distribution channels and increased availability of olanzapine to patients. This shift could contribute to the market reaching 3.58 USD Billion by 2035, reflecting a broader commitment to mental health care.

Growing Awareness and Education on Mental Health

The rise in awareness and education surrounding mental health issues is a significant driver for the Global Olanzapine Market Industry. Campaigns aimed at reducing stigma and promoting understanding of mental health disorders have led to more individuals seeking treatment. This increased awareness not only encourages patients to pursue medications like olanzapine but also informs healthcare providers about the importance of timely intervention. As more people recognize the signs and symptoms of mental health disorders, the demand for effective treatments is expected to rise, further propelling the growth of the Global Olanzapine Market Industry.

Regulatory Support for Antipsychotic Medications

Regulatory bodies are increasingly supportive of antipsychotic medications, which plays a crucial role in the growth of the Global Olanzapine Market Industry. Streamlined approval processes and guidelines for the use of olanzapine in various mental health conditions facilitate quicker access for patients. This regulatory environment encourages pharmaceutical companies to invest in the development and marketing of olanzapine, thereby expanding its reach. As regulations evolve to support mental health treatment, the market is poised for growth, with olanzapine likely to remain a key player in the therapeutic landscape.

Market Segment Insights

Regional Insights

Key Companies in the Olanzapine Market market include

Industry Developments

The Olanzapine market is expanding in emerging markets such as the Middle East and Africa. This development will lead to new developments and growth in the olanzapine market.

Future Outlook

Olanzapine Market Future Outlook

The Global Olanzapine Market is projected to grow at a 2.77% CAGR from 2024 to 2035, driven by increasing mental health awareness and innovative drug formulations.

New opportunities lie in:

Expand telehealth services to enhance patient access to Olanzapine prescriptions.
Invest in research for novel delivery systems to improve patient compliance.
Develop partnerships with mental health organizations to promote Olanzapine awareness.

By 2035, the Olanzapine Market is expected to demonstrate robust growth, reflecting evolving healthcare needs and advancements in treatment options.

Market Segmentation

Olanzapine Types Outlook

ZYPREXA intramuscular
ZYPREXA tablets
ZYPREXA ZDIS

Olanzapine Segment Outlook

Bipolar disorder
Schizophrenia

Olanzapine Regional Outlook

Europe
Asia pacific
North America
Dr ready’s laboratory
Watson pharmaceuticals
Lilly
Hamson pharmaceuticals
Sun pharmaceuticals
Sandoz pharmaceuticals
Torrent pharmaceuticals
Jubilant lifescientist
The Olanzapine market is expanding in emerging markets such as the Middle East and Africa. This development will lead to new developments and growth in the olanzapine market.
Market overview highlights
Analysis based upon COVID 19
Explanation upon the Market Dynamics
Value chain analysis
Market segmentation overview
The regional analysis
Competitive landscape analysis
Recent Developments
Beta

Report Scope

Report Attribute/Metric	Details
Market Size 2023	2.3 (USD Billion)
Market Size 2024	2.65 (USD Billion)
Market Size 2032	3.1 (USD Billion)
Compound Annual Growth Rate (CAGR)	4.9 % (2024 - 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2024 - 2032
Historical Data	2019 - 2023
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	WATSON Pharmaceuticals(Changzhou), Hanson Pharmaceutical, Sandoz, Zhejiang Langhua Pharmaceuticals, Hansoh Pharmaceutical, Aurobindo Pharma, Jubilant Lifesciencest, Torrent Pharmaceuticals, Sun Pharmaceutical, Lilly, Dr. Reddy’s Laboratories, Mylan Pharmaceuticals, Apotex Inc., Teva Pharmaceutical
Key Market Opportunities	Olanzapine has been very effective drug but it also has some negative aspects like agitation, dysarthria with others.
Key Market Drivers	Increase in the population of various countries.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Latest Comments

John Doe

[email protected]

This is a great article! Really helped me understand the topic better.

Posted on July 23, 2025, 10:15 AM

Jane Smith

[email protected]

Thanks for sharing this. I’ve bookmarked it for later reference.

Posted on July 22, 2025, 7:45 PM

View All

FAQs

What are the diseases in which olanzapine finds good use?

Olanzapine market finds good use in the treatment of bipolar disorder, schizophrenia, and other neurological disorders.

Which is the fastest-growing olanzapine market?

Asia Pacific is the fastest-growing olanzapine market.

Which is the largest olanzapine market?

Asia Pacific is the largest olanzapine market.

Which country in the Asia Pacific would lead the olanzapine market?

China would lead the Asia Pacific olanzapine market.

What are the types mentioned in the olanzapine market report?

The types of olanzapine are ZYPREXA ZYDIS, ZYPREXA tablets, and ZYPREXA IntraMuscular

Name key players of the global olanzapine market.

Hanson Pharmaceutical, Lilly, Mylan Pharmaceuticals, Jubilant Lifesciences, Aurobindo Pharma, Sandoz, Teva Pharmaceutical, Zhejiang Langhua Pharmaceuticals, Apotex Inc., WATSON Pharmaceuticals, Hansoh Pharmaceutical, Dr. Reddy’s Laboratories, Torrent Pharmaceuticals, and Sun Pharmaceutical are key players of the global olanazapine market.

'TABLE OF CONTENTS
EXECUTIVE SUMMARY
MARKET INTRODUCTION
1. Definition
2. Scope of the Study
  1. Research Objective
  2. Assumptions
  3. Limitations
RESEARCH METHODOLOGY
1. Overview
2. Data Mining
3. Secondary Research
4. Primary Research
  1. Primary Interviews
and Information Gathering Process
1. Breakdown of Primary Respondents
2. Forecasting Technique
3. Market Size Estimation
  1. Bottom-Up Approach
  2. Top-Down Approach
4. Data Triangulation
5. Validation
MARKET DYNAMICS
1. Overview
2. Drivers
3. Restraints
4. Opportunities
MARKET FACTOR ANALYSIS
1. Value Chain Analysis
2. Porter’s Five Forces Analysis
  1. Bargaining Power
of Suppliers
Bargaining Power of Buyers
1. Threat of New Entrants
  1. Threat of Substitutes
  2. Intensity of Rivalry
2. COVID-19 Impact Analysis
  1. Market Impact Analysis
  2. Regional Impact
  3. Opportunity and
Threat Analysis
GLOBAL OLANZAPINE MARKET, BY APPLICATION
1. Overview
2. Schizophrenia
3. Bipolar disorder
4. Others
GLOBAL OLANZAPINE MARKET, BY TYPE
1. Overview
2. Zyprexa Tablets
3. Zyprexa ZYDIS
4. Zyprexa IntraMuscular
GLOBAL OLANZAPINE
MARKET, BY REGION
Overview
North America
US
1. Canada
2. Europe
  1. Germany
  2. France
  3. UK
  4. Italy
  5. Spain
  6. Rest of Europe
3. Asia-Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Australia
  6. Rest of Asia-Pacific
4. Rest of the World
  1. Middle East
  2. Africa
  3. Latin America
COMPANY LANDSCAPE
1. Overview
2. Competitive Analysis
3. Market Share Analysis
4. Major Growth Strategy
in the Global Olanzapine Market
1. Competitive Benchmarking
2. Leading Players in Terms of Number of Developments
3. Key developments and Growth Strategies
  1. New Product Launch
  2. Merger & Acquisitions
  3. Joint Ventures
4. Major Players Financial
Matrix
Sales & Operating Income, 2022
1. Major Players R&D Expenditure. 2022
COMPANY PROFILES
1. Watson Pharmaceuticals
  1. Company Overview
  2. Financial Overview
  3. Product Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
2. Hamson Pharmaceutical
  1. Company Overview
  2. Financial Overview
  3. Product Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
3. Sandoz Pharmaceuticals
  1. Company Overview
  2. Financial Overview
  3. Product Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
4. Zhejiang Langhua
Pharmaceutical.
Company Overview
Financial Overview
Product Offered
Key Developments
SWOT Analysis
Key Strategies
Hansoh Pharmaceutical
Jubilant Pharmova Limited
1. Company Overview
  1. Financial Overview
  2. Product Offered
  3. Key Developments
  4. SWOT Analysis
  5. Key Strategies
2. Torrent Pharmaceuticals
  1. Company Overview
  2. Financial Overview
  3. Product Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
3. Sun Pharmaceuticals
  1. Company Overview
  2. Financial Overview
  3. Product Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
4. Dr. Reddy’s Laboratories
  1. Company Overview
  2. Financial Overview
  3. Product Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
5. Mylan Pharmaceuticals
  1. Company Overview
  2. Financial Overview
  3. Product Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
APPENDIX
1. References
2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL OLANZAPINE MARKET,
SYNOPSIS, 2023-2030
TABLE
GLOBAL OLANZAPINE MARKET, ESTIMATES & FORECAST, 2023-2030 (USD MILLION)
TABLE 3 GLOBAL OLANZAPINE
MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 4 GLOBAL OLANZAPINE MARKET, BY TYPE, 2023-2030
(USD MILLION)
GLOBAL OLANZAPINE MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 6 NORTH AMERICA: OLANZAPINE
TABLE 7 NORTH AMERICA: OLANZAPINE MARKET, BY TYPE,
2030 (USD MILLION)
TABLE 8 NORTH AMERICA: OLANZAPINE MARKET, BY COUNTRY, 2023-2030 (USD
MILLION)
US: OLANZAPINE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 10 US: OLANZAPINE MARKET,
BY TYPE, 2023-2030 (USD MILLION)
TABLE 11 CANADA: OLANZAPINE MARKET, BY APPLICATION, 2023-2030 (USD
CANADA: OLANZAPINE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 13 EUROPE: OLANZAPINE MARKET,
BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 14 EUROPE: OLANZAPINE MARKET, BY TYPE, 2023-2030 (USD
EUROPE: OLANZAPINE MARKET, BY COUNTRY 2023-2030 (USD MILLION)
TABLE 16 GERMANY: OLANZAPINE
TABLE 17 GERMANY: OLANZAPINE MARKET, BY TYPE, 2023-2030
FRANCE: OLANZAPINE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 19 FRANCE: OLANZAPINE
MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 20 ITALY: OLANZAPINE MARKET, BY APPLICATION, 2023-2030
ITALY: OLANZAPINE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 22 SPAIN: OLANZAPINE MARKET,
TABLE 23 SPAIN: OLANZAPINE MARKET, BY TYPE, 2023-2030 (USD
UK: OLANZAPINE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 25 UK: OLANZAPINE MARKET,
TABLE 26 REST OF EUROPE: OLANZAPINE MARKET, BY APPLICATION, 2023-2030
REST OF EUROPE: OLANZAPINE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 28 ASIA-PACIFIC:
OLANZAPINE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC: OLANZAPINE MARKET, BY TYPE,
TABLE 30 ASIA-PACIFIC: OLANZAPINE MARKET, BY COUNTRY, 2023-2030 (USD
JAPAN: OLANZAPINE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 32 JAPAN: OLANZAPINE MARKET,
TABLE 33 CHINA: OLANZAPINE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 34 CHINA: OLANZAPINE
TABLE 35 INDIA: OLANZAPINE MARKET, BY APPLICATION, 2023-2030
INDIA: OLANZAPINE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 37 AUSTRALIA: OLANZAPINE
TABLE 38 AUSTRALIA: OLANZAPINE MARKET, BY TYPE, 2023-2030
SOUTH KOREA: OLANZAPINE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 40 SOUTH KOREA:
OLANZAPINE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 41 REST OF ASIA-PACIFIC: OLANZAPINE MARKET,
TABLE 42 REST OF ASIA-PACIFIC: OLANZAPINE MARKET, BY TYPE,
TABLE 43 REST OF THE WORLD: OLANZAPINE MARKET, BY APPLICATION, 2023-2030
REST OF THE WORLD: OLANZAPINE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 45 REST OF THE
WORLD: OLANZAPINE MARKET, BY COUNTRY 2023-2030 (USD MILLION)
TABLE 46 MIDDLE EAST: OLANZAPINE
TABLE 47 MIDDLE EAST: OLANZAPINE MARKET, BY TYPE,
TABLE 48 AFRICA: OLANZAPINE MARKET, BY APPLICATION, 2023-2030 (USD
AFRICA: OLANZAPINE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 50 LATIN AMERICA: OLANZAPINE
TABLE 51 LATIN AMERICA: OLANZAPINE MARKET, BY TYPE,
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL OLANZAPINE MARKET
FIGURE 3 MARKET DYNAMICS
FOR THE GLOBAL OLANZAPINE MARKET
FIGURE 4 GLOBAL OLANZAPINE MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 5 GLOBAL OLANZAPINE
MARKET, SHARE (%), BY TYPE, 2022
FIGURE 6 GLOBAL OLANZAPINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 NORTH AMERICA:
OLANZAPINE MARKET, SHARE (%), BY COUNTRY, 2022
FIGURE 8 EUROPE: OLANZAPINE MARKET, SHARE (%), BY
COUNTRY, 2022
FIGURE
ASIA-PACIFIC: OLANZAPINE MARKET, SHARE (%), BY COUNTRY, 2022
FIGURE 10 REST OF THE WORLD:
FIGURE 11 GLOBAL OLANZAPINE MARKET: COMPANY SHARE
ANALYSIS (%), 2022
WATSON PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 WATSON PHARMACEUTICALS: SWOT ANALYSIS
FIGURE 14 HAMSON PHARMACEUTICAL:
OVERVIEW SNAPSHOT
HAMSON PHARMACEUTICAL: SWOT ANALYSIS
FIGURE 16 SANDOZ PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 SANDOZ PHARMACEUTICALS:
ZHEJIANG LANGHUA PHARMACEUTICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 ZHEJIANG LANGHUA PHARMACEUTICAL:
HANSOH PHARMACEUTICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 HANSOH PHARMACEUTICAL: SWOT ANALYSIS
FIGURE 22 JUBILANT PHARMOVA
LIMITED OVERVIEW SNAPSHOT
FIGURE 23 JUBILANT PHARMOVA LIMITED: SWOT ANALYSIS
FIGURE 24 TORRENT PHARMACEUTICALS:
FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 TORRENT PHARMACEUTICALS: SWOT ANALYSIS
FIGURE 26 SUN PHARMACEUTICAL:
FIGURE 27 SUN PHARMACEUTICAL: SWOT ANALYSIS
FIGURE 28 DR. REDDY’S LABORATORIES: FINANCIAL
DR. REDDY’S LABORATORIES: SWOT ANALYSIS
FIGURE 30 MYLAN PHARMACEUTICALS: FINANCIAL OVERVIEW
SNAPSHOT
MYLAN PHARMACEUTICALS: SWOT ANALYSIS'

Olanzapine Market Segmentation

Market Segmentation Overview

Detailed segmentation data will be available in the full report
Comprehensive analysis by multiple parameters
Regional and country-level breakdowns
Market size forecasts by segment

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027